epcoritamab,glofitamab
roche,abbvie,genmab
['dlbcl', 'epcoritamab', '$gmab', '$rhhby', 'genentech']
latest from #eha2022, ph ii data for #epcoritamab cd20 bispecific shows best-in-class potential in r/r dlbcl: a biocentury data byte comparing asco data $gmab $rhhby 
The leading voice for decision-makers throughout the global biopharma ecosystem. 
Free weekly podcast "BioCentury This Week": https://t.co/6CfHh0mIT6